Literature DB >> 11405653

Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines.

J Easmon1, G Pürstinger, G Heinisch, T Roth, H H Fiebig, W Holzer, W Jäger, M Jenny, J Hofmann.   

Abstract

A series of thiosemicarbazones (TSCs) (bearing a (4)N-azabicyclo[3.2.2]nonane moiety) derived from 3-acylpyridazines, 4-acetylpyrimidines, and 2-acetylpyrazines (1-8) were synthesized as potential antitumor agents. TSCs 1-8 exhibited potent cytotoxic activity against human acute lymphoblastic leukemia CCRF-CEM cells (IC(50) = 0.05-0.77 microM) and colon adenocarcinoma HT-29 cells (IC(50) = 0.011-2.22 microM). Copper II complexes of TSCs 1-8 showed significant improvement in cytotoxic activity against HT-29 cells (IC(50) = 0.004-1.51 microM) by a factor of 3. However, complexation of ligands 1, 2, 4, and 6 with Fe(II) results in lowering of cytotoxic activity by a factor of approximately 7. In clonogenic assays involving human tumor cells of different tumor origins, compounds 5, 7, 8, and their copper complexes 5Cu(II), 7Cu(II), and 8Cu(II) exhibited remarkable cytotoxic activities with mean IC(50) values of 6, 0.18, 1, 1, 0.37, and 0.37 nM, respectively. In particular, the compounds were highly effective against human colon carcinoma and large and small cell lung carcinoma cells. The TSC derivative 5 was evaluated in vivo in nude mice bearing LXFL 529 human large cell lung carcinoma cells. With respect to antitumor activity, application of 30 mg/kg/d resulted in moderate inhibition (42%) of tumor growth. No effect on tumor growth was observed at a dose of 10 mg/kg/d. However, a dose of 40 or 60 mg/kg/d resulted in 50 and 75% death, respectively, in the treated mice, indicating the high toxicity of these compounds. Using human liver microsomes, compound 5 was found to be rapidly and highly metabolized in vitro. In actual fact, only 2% of the unmetabolized compound could be detected in the incubation medium after 5 min. The IC(50) for cell proliferation (0.006-0.022 microM) elicited by these compounds is much lower than that of the inhibition of [(14)C]cytidine incorporation into DNA (0.18-3.32 microM). These compounds are also noncell cycle specific agents. Interestingly, compounds 5, 5Cu(II), and 8 were found to be potent inducers of apoptosis in Burkitt's lymphoma cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405653     DOI: 10.1021/jm000979z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

1.  Synthesis and crystal structures of novel copper(II) complexes with glycine and substituted phenanthrolines: reactivity towards DNA/BSA and in vitro cytotoxic and antimicrobial evaluation.

Authors:  Duygu İnci; Rahmiye Aydın; Özgür Vatan; Tuba Sevgi; Dilek Yılmaz; Yunus Zorlu; Yusuf Yerli; Bünyemin Çoşut; Elif Demirkan; Nilüfer Çinkılıç
Journal:  J Biol Inorg Chem       Date:  2016-11-10       Impact factor: 3.358

2.  URD12: A urea derivative with marked antitumor activities.

Authors:  Ai-Yun Wang; Yin Lu; Hai-Liang Zhu; Qing-Cai Jiao
Journal:  Oncol Lett       Date:  2011-11-08       Impact factor: 2.967

3.  Silver(I) metallodrugs of thiosemicarbazones and naproxen: biocompatibility, in vitro anti-proliferative activity and in silico interaction studies with EGFR, VEGFR2 and LOX receptors.

Authors:  Sundaram Bharathi; Dharmasivam Mahendiran; Raju Senthil Kumar; Hyo Jeong Choi; Mani Gajendiran; Kyobum Kim; Aziz Kalilur Rahiman
Journal:  Toxicol Res (Camb)       Date:  2020-03-11       Impact factor: 3.524

4.  Role of metalation in the topoisomerase IIα inhibition and antiproliferation activity of a series of α-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes.

Authors:  Brian M Zeglis; Vadim Divilov; Jason S Lewis
Journal:  J Med Chem       Date:  2011-03-10       Impact factor: 7.446

5.  QSAR studies of copper azamacrocycles and thiosemicarbazones: MM3 parameter development and prediction of biological properties.

Authors:  Peter Wolohan; Jeongsoo Yoo; Michael J Welch; David E Reichert
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

6.  Synthesis, Structural, DNA Binding and Cleavage Studies of Cu(II) Complexes Containing Benzothiazole Cored Schiff Bases.

Authors:  Somapangu Tejaswi; Marri Pradeep Kumar; Aveli Rambabu; Narendrula Vamsikrishna
Journal:  J Fluoresc       Date:  2016-08-27       Impact factor: 2.217

7.  A New Thiosemicarbazone-Based Fluorescence "Turn-on" Sensor for Zn(2+) Recognition with a Large Stokes Shift and its Application in Live Cell Imaging.

Authors:  Lijun Tang; Zhenlong Huang; Zhuxuan Zheng; Keli Zhong; Yanjiang Bian
Journal:  J Fluoresc       Date:  2016-06-22       Impact factor: 2.217

8.  Novel ethanocycloheptono [3,4,5-kl]benzo[a]xanthene induces apoptosis in BEL-7402 cells.

Authors:  Zhi Jia; Hui-Hui Yang; Yun-Jun Liu; Xiu-Zhen Wang
Journal:  Mol Cell Biochem       Date:  2018-01-27       Impact factor: 3.396

9.  Synthesis and characterization of new copper thiosemicarbazone complexes with an ONNS quadridentate system: cell growth inhibition, S-phase cell cycle arrest and proapoptotic activities on cisplatin-resistant neuroblastoma cells.

Authors:  Haiyuan Zhang; Ronald Thomas; David Oupicky; Fangyu Peng
Journal:  J Biol Inorg Chem       Date:  2007-10-02       Impact factor: 3.358

10.  Evaluation of antiproliferative activities and apoptosis induction caused by copper(II)-benzothiazolesulfonamide complexes in Jurkat T lymphocytes and Caco-2 cells.

Authors:  Marta González-Alvarez; Gloria Alzuet; Joaquín Borrás; Lucas del Castillo-Agudo; Jose Manuel Montejo-Bernardo; Angel Gutiérrez-Rodríguez; Santiago García-Granda
Journal:  J Biol Inorg Chem       Date:  2008-07-24       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.